MEMS  

 
  MEMS  
About MEMS   |   Council   |   Members Centre   |   Membership   |   Contact Us   |   Home
  Member Login     username:     password:           Forgot your password?
  Home » Breaking News & Reports » 
President’s Message
The Endocrine Directory
Calendar of Events
Announcements & Updates
Breaking News & Reports
CME
CPG
In the Press
Disease Areas
Healthy Lifestyle
Publications
Research Programs
Awards
Photo & Video Gallery
Useful Links
Disease Management
Home
 
arrow The Chicago Diabetes Project - Global Collaboration For A Functional Cure
14-07-2010
In the last 20 years, a vast amount of scientific knowledge has been gathered about how insulin-producing cells develop, function and survive in the normal human body and how they
»Read more...
 


arrow TZDs: Are We Done Yet? The RECORD Study
6-07-2010
The introduction of thiazolidinedione (TZD) in the late 1990s heralded a new landmark in the management of diabetes mellitus.It was the first among the anti-diabetic agents that specifically addressed the issue of insulin resistance; the major underlying pathophysiology of type 2 diabetes mellitus (T2DM).
»Read more...
 


arrow New Position Statement on Menopausal Hormone Therapy
5-07-2010
The Endocrine Society (USA) issued a scientific statement titled "Postmenopausal Hormone Therapy: An Endocrine Society Scientific Statement" that was published in the July 2010 issue of the Journal of Clinical Endocrinology & Metabolism (JCEM).
»Read more...
 


arrow FDA Warning: Some patients cannot process Clopidogrel (Plavix)
15-03-2010
FDA puts black box warning on Plavix, says certain patients can't process blood thinner. The Food and Drug Administration is adding its strongest warning to the label for Plavix, cautioning that some patients do not respond to the blockbuster blood thinner.
»Read more...
 


arrow Check statin users for diabetes
17-02-2010
Statin therapy increases the risk of diabetes and patients taking the drugs should have their blood glucose monitored on a regular basis, according to articles published in the Lancet today. A meta-analysis of 13 statin trials with more than 90,000 patients found that use of the drugs was associated with a 9% increased risk of diabetes over four years. The risk seemed higher in trials with older participants.
»Read more...
 


 
   
 



 
 
| | | |
© Copyright Malaysian Endocrine & Metabolic Society (MEMS)   2009 - 2016    All rights reserved.
designed & maintained: mobition